Drug Type Small molecule drug |
Synonyms 2-methyl-5,7-dichloro-8-hydroxyquinoline, 5,7-dichloro-2-methyl-8-hydroxyquinoline, 5,7-dichloro-2-methyl-8-quinolinol + [6] |
Target |
Action agonists |
Mechanism MTRR agonists(5-methyltetrahydrofolate-homocysteine methyltransferase reductase agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (04 Jan 2005), |
Regulation- |
Molecular FormulaC10H7Cl2NO |
InChIKeyGPTXWRGISTZRIO-UHFFFAOYSA-N |
CAS Registry72-80-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acne Vulgaris | China | 04 Jan 2005 | |
Bacterial Infections | China | 04 Jan 2005 | |
Skin Diseases, Infectious | China | 04 Jan 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Fibrosis | Preclinical | China | 28 Aug 2024 |